News Focus
News Focus
icon url

raja48185

02/27/21 4:55 PM

#300970 RE: falconer66a #300966

Thanks for the input.
icon url

powerwalker

02/27/21 5:22 PM

#300979 RE: falconer66a #300966

falconer, another outstanding piece of explaining this disease. We are so glad and blessed that you found this MB.

By chance, do you have a photographic memory?

If Patrick Cox does come back to write about Anavex, he needs you to be his scientific/biology resource.

Peace, falconer, and have a great weekend,
Powerwalker



ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
icon url

frrol

02/28/21 12:02 AM

#301008 RE: falconer66a #300966

The 2016 FMR1 study with 2-73 was very promising, and I'm looking forward to our Fragile X clinical trial. It's clearly worth pursuing, especially with our Rett outcomes coming in strong.

The recent S1 chromatin modulation function might indeed be the key, and explain and support the 2016 study. The company is clearly excited even more now to test in the clinic.
icon url

McMagyar

02/28/21 5:43 AM

#301016 RE: falconer66a #300966

Another awesome , well iterated, delightfully explanative post.

how many other neuro developmental diseases may be included
in this mold? The genes are within the code, but not properly expressed by chromatin?